Abstract
In the present study, we report a more detailed biochemical analysis of the B16 melanoma, metastasis-associated, Met-72 antigen. Specifically, we have examined (1) the molecular forms of Met-72 isolated during synthesis, surface expression and ‘shedding’ and (2) the cell-surface expression of Met-72 during the cell cycle. These experiments show that the 72 kD species originally described [20] has an isoelectric point of between 6·3 and 6·9, but is the desialylated derivative of an 83 kD native molecule whose isolectric point ranges between pH 4·9 and 5·6. In addition, a 90 kD glycoprotein doublet was immunoprecipitated from biosynthetically labelled B16 melanoma cells, but does not appear to be a precursor of the 83 kD or 72 kD molecule. These findings have led us to interchangeably use the terminology Met-72 and Met 72/83. The latter terminology more accurately describes the physical forms which can be identified by different labelling procedures. When culture supernatants from3H-leucine labelled cells were subjected to anti-Met-72 immunoprecipitation, a 35 kD species was identified as a possible ‘shed’ product of these cells. Met-72/83 expression during the cell cycle was analyzed by flow cytometry and found not to be restricted to any particular stage.
In addition, experiments were performed to determine whether low levels of Met-72 expression on poorly metastatic B16 melanomal clones was a direct result of low levels of synthesis, or if other control mechanisms regulated intracellular pools of Met-72 prior to cell-surface expression.
Similar content being viewed by others
Abbreviations
- FACS:
-
fluorescence activated cell sorter
- FBS:
-
fetal bovine serum
- FITC:
-
fluorescein isothiocyanate
- IEF:
-
isoelectric focusing
- MAA:
-
melanoma associated antigen
- MoAb:
-
monoclonal antibody
- PBS:
-
phosphate buffered saline without Ca2+ or Mg2+
- SDS-PAGE:
-
sodium dodecyl sulphate-polyacrylamide gel electrophoresis
References
Anderson, L., andAnderson, N., 1977, High resolution two dimensional electrophoresis of human plasma proteins.Proceedings of the National Academy of Science U.S.A.,74, 5421–5425.
Bhavanandan, V. P., Kemper, J. G., andBystryn, J.-C., 1980, Purification and partial characterization of a murine melanoma-associated antigen.Journal of Biological Chemistry,255, 5145–5153.
Bonner, W. M., andLaskey, R. A., 1974, A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.European Journal of Biochemistry,46, 83–90.
Braylan, R. C., Benson, N. A., Nourse, V., andKruth, H. S., 1982, Correlated analysis of cellular DNA, membrane antigens and light scatter of human lymphoid cells.Cytometry,2, 337–343.
Bystryn, J.-C., 1977, Release of cell-surface tumor-associated antigens by viable melanoma cells from humans.Journal of the National Cancer Institute,59, 325–328.
Bystryn, J.-C., 1978, Antibody response and tumor growth in syngeneic mice immunized to partially purified B16 melanoma associated antigens.Journal of Immunology,120, 96–101.
Bystryn, J.-C., Schenkein, I., Bauer, S., andUhr, J., 1974, Partial isolation and characterization of antigens associated with murine melanoma.Journal of the National Cancer Institute,52, 1263–1269.
Bystryn, J.-C., Tedholm, C. A., andHeaney-Kieras, J., 1981, Release of surface macromolecules by human melanoma and normal cells.Cancer Research,41, 910–914.
Doyle, D., Baumann, H., England, B., Friedman, E., Hou, E., andTweto, J., 1978, Biogenesis of plasma membrane glycoproteins in hepatoma tissue culture cells.Journal of Biological Chemistry,253, 965–973.
Eisinger, R. W., andKenknel, S. J., 1981, Heterogeneity of a labelled tumor surface protein from murine lung adenoma demonstrated by two-dimensional electrophoresis.Cancer,41, 877–881.
Gersten, D. M., andMarchalonis, J. J., 1979, Demonstration and isolation of murine melanoma associated antigenic surface proteins.Biochemical Biophysical Research Communications,90, 1015–1024.
Hearing, V. J., Gersten, D. M., Montague, P. M., Vieira, W. D., Galetto, G., andLaw, L. W., 1986, Murine melanoma-specific tumor rejection activity selected by a purified, melanoma-associated antigen.Journal of Immunology,137, 379–384.
Heukeshoven, J., andDernick, R., 1985, Simplified method for silver staining of proteins in polyacrylamide gels and the mechanism of silver staining.Electrophoresis,6, 103–112.
Jones, P. P., 1980, Analysis of radiolabelled lymphocyte proteins by one- and two-dimensional polyacrylamide gel electrophoresis.Selected methods in cellular immunology, edited by R. B. Misehel and S. M. Shiigi (San Francisco: W. H. Freeman), pp. 398–440.
Kessler, S., 1976, Cell membrane antigen isolation with the Staphylococcal protein A-antibody absorbent.Journal of Immunology,117, 1482–1490.
Khan, A., Grammer, S., Chang, D., Hill, N. O., andMiller, J., 1983, Mouse monoclonal antibody (WI-MN-I) against malignant melanoma.Cancer Research,43, 5868–5872.
Kimura, A., andErsson, B., 1981, Activation of T lymphocytes by lectins and carbohydrate-oxidizing reagents viewed as an immunological recognition of cell-surface modifications seen in the context of self major histocompatibility antigens.European Journal of Immunology,11, 475–483.
Kimura, A. K., Mehta, P., Xiang, J., Lawson, D., Dugger, D., Kao, K.-J., andLee-Ambrose, 1987, The lack of correlation between experimental metastatic potential and platelet aggregating activity of B16 melanoma clones viewed in relation to tumor cell heterogeneity.Clinical and Experimental Metastasis,5, 125–133.
Kimura, A. K., andWigzell, H., 1978, Cell-surface glycoproteins of murine cytotoxic T lymphocytes.Journal of Experimental Medicine,147, 1418–1434.
Kimura, A. K., andXiang, J., 1986, High levels of Met-72 antigen expression: correlation with metastatic activity of B16 melanoma tumor cell variants.Journal of the National Cancer Institute,76, 1247–1254.
Kruth, H. A., Braylan, R. C., Benson, N. A., andNourse, V. A., 1981, Simultaneous analysis of DNA and cell surface immunoglobulin in human B-cell lymphomas by flow cytometry.Cancer Research,41, 4895–4899.
Laemmli, U. K., 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4.Nature,227, 680–685.
Nishio, C., Ishii, Y., Ishii, K., andKikuchi, K., 1982, Identification of an oncofetal antigen (gp 90) on murine B16 melanoma cells.European Journal of Cancer Oncology,18, 579–588.
North, S. M., Steck, P. A., andNicolson, G. L., 1986, Monoclonal antibodies against cell surface antigens of the metastatic rat 1376NF mammary adenocarcinoma and their cross-reactivity with human breast carcinoma.Cancer Research,46, 6393–6399.
Olsson, L., andForchhammer, J., 1984, Induction of the metastatic phenotype in a mouse tumor model by 5-azacytidine, and characterization of an antigen associated with metastatic activity.Proceedings of the National Academy of Science, U.S.A.,91, 3389–3393.
Parratto, N., andKimura, A. K., 1988, Immunohistochemical characterization of the B16 melanoma and localization of its metastatic variantsin situ.Journal of Cellular Biochemistry,36, 311–322.
Poskitt, P. K. F., Poskitt, T. R., andWallace, J. H., 1976, Release into culture medium of membrane-associated, tumor specific antigen by B16 melanoma cells.Proceedings of the Society for Experimental Biology and Medicine,52, 76–80.
Tomita, Y., Montague, P. M., andHearing, V. J., 1985, Monoclonal antibody production to a B16 melanoma asssociated antigen.International Journal of Cancer,35, 543–547.
Vollmers, H. P., andBirchmeier, W., 1983, Monoclonal antibodies inhibit the adhesion of mouse B16 melanoma cellsin vitro and block lung metastasisin vivo.Proceedings of the National Academy of Sciences, U.S.A.,80, 3729–3733.
Wieland, I., Muller, G., Graun, S., andBirchmeier, W., 1986, Reversion of the transformed phenotype of B16 mouse melanoma: involvement of an 83 kD cell surface glycoprotein in specific growth inhibition.Cell,47, 675–685.
Xiang, J., andKimura, A. K., 1986,In vitro modulation of the metastatic phenotype. I. Analysis of differentiation forms of the B16 melanoma expressing Met-72 determinants and metastatic activity.Clinical and Experimental Metastasis,4, 293–309.
Xiang, J., andKimura, A. K., 1987, Isolation of metastatic B16 melanoma variants using anti-Met-72 monoclonal antibodies and flow cytometry.Clinical and Experimental Metastasis,5, 35–42.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Xiang, J., Kimura, A.K. & Hansen, J.P. Synthesis and expression of metastasis-associated, Met-72/83 antigens. Clin Exp Metast 6, 473–483 (1988). https://doi.org/10.1007/BF01784378
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01784378